Billing and Coding Article Updates for July 2023

Billing and Coding: Bevacizumab and Biosimilars (A52370)

Based on Compendia review, ICD-10 codes Z85.09 and Z85.42 have been added to the Group 1 code list effective for dates of service on or after 7/1/2023.

Billing and Coding: Bortezomib (A52371)

Based on compendia review, ICD-10 code C91.01 has been added effective for dates of service on or after 7/1/2023.

Billing and Coding: Infliximab and Biosimilars (A52423)

Based on Transmittal 12067 (CR 13056) - New Claims Modifier Requirement for Drugs and Biologicals from a Single-Dose Container or Single-Use Package, Modifier JZ has been added to Coding Information #2 in the "Article Text" section of the article.

Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG) (A59105)

Based on Transmittal 12072 (CR 13208) - Quarterly Update to the Medicare Physician Fee Schedule Database (MPFSDB) - July 2023 Update, HCPCS code J1576 has been added.

Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™) (A52450)

Per Transmittal 12072 (CR 13208) - Quarterly Update to the Medicare Physician Fee Schedule Database (MPFSDB) - July 2023 Update, HCPCS Code J9259 has been added. Based on compendia review, ICD-10 codes Z85.09 and Z85.42 have been added to the Group 1 codes for albumin-bound paclitaxel and ICD-10 code Z85.42 has been added for paclitaxel effective for dates of service on or after 7/1/2023.

Billing and Coding: Sacroiliac Joint Injections and Procedures – A59233

Revision Effective Date: 3/19/2023
Editorial/clarification updates have been made to the Coding Guidance section.

Posted 6/27/2023